Source: Υπουργείο Υγείας (CY) Revision Year: 2021 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Imuprin 50 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Yellow, round, film-coated tablets, scored and embossed with AZA and 50 on the same side. The score line is not intended for breaking the tablet. |
Each film-coated tablet contains 50 mg azathioprine.
Excipient(s) with known effect: This product contains 69.8 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Azathioprine |
Azathioprine is a pro-drug of 6-mercaptopurine (6-MP). 6-MP is inactive but acts as a purine antagonist and requires cellular uptake and intracellular anabolism to thioguanine nucleotides (TGNs) for immunosuppression. The TGNs and other metabolites (e.g. 6-methyl-mecaptopurine ribonucleotides) inhibit de novo purine synthesis and purine nucleotide interconversions. |
| List of Excipients |
|---|
|
Core: Lactose monohydrate Coating: Hypromellose |
PVC/Aluminium blisters. Pack sizes of 20, 100 and 1000 film-coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
9030
Date of first authorization: 15 September 1983
Date of latest renewal: 27 February 2009
| Drug | Countries | |
|---|---|---|
| IMUPRIN | Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
